Dashboard
Manage Tickers

LCTX Lineage Cell Therapeutics, ...

NYSE lineagecell.com


$ 1.73 $ -0.02 (-1.16 %)    

Wednesday, 29-Oct-2025 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 634.74 $ 2.85 (0.45 %)
DIA $ 476.09 $ -0.78 (-0.16 %)
SPY $ 686.84 $ 0.33 (0.05 %)
TLT $ 90.87 $ -0.93 (-1.01 %)
GLD $ 363.50 $ -1.38 (-0.38 %)
$ 1.71
$ 1.75
$ 1.66 x 45
$ 1.79 x 200
$ 1.66 - $ 1.75
$ 0.37 - $ 1.85
1,192,178
na
390.49M
$ 1.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-10-2025 12-31-2024 10-K
4 11-14-2024 09-30-2024 10-Q
5 08-08-2024 06-30-2024 10-Q
6 05-09-2024 03-31-2024 10-Q
7 03-07-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-09-2023 12-31-2022 10-K
12 11-10-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-10-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-11-2021 12-31-2020 10-K
20 11-04-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-12-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 03-14-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-15-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-04-2016 09-30-2016 10-Q
37 08-09-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-15-2016 12-31-2015 10-K
40 11-09-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
09/22/2025 21:06:10

lineage-cell-therapeutics-announces-launch-of-a-new-islet-cell-transplant-program-targeting-type-1-diabetes
Lineage Cell Therapeutics Announces Launch...
09/08/2025 12:01:43

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogen...

5-analysts-assess-lineage-cell-therapeutics-what-you-need-to-know
5 Analysts Assess Lineage Cell Therapeutic...
08/27/2025 18:01:25

d-boral-capital-maintains-buy-on-lineage-cell-therapeutics-maintains-2-price-target
D. Boral Capital Maintains Buy on Lineage ...
08/27/2025 12:17:51

D. Boral Capital analyst Jason Kolbert maintains Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $2 price tar...

lineage-and-william-demant-collaborate-through-investment-to-develop-resonance-for-hearing-loss
Lineage And William Demant Collaborate Thr...
08/26/2025 12:05:34

Three-year term intended to advance preclinical development of ReSonanceUp to $12 million of development costs to be contribute...

Core News & Articles
12 Health Care Stocks Moving In Friday's I...
08/15/2025 17:07:19

d-boral-capital-maintains-buy-on-lineage-cell-therapeutics-maintains-2-price-target
D. Boral Capital Maintains Buy on Lineage ...
08/14/2025 12:32:34

D. Boral Capital analyst Jason Kolbert maintains Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $2 price tar...

update-lineage-cell-therapeutics-q2-adj-eps-007-misses-003-estimate-sales-2765m-beat-1472m-estimate
Update: Lineage Cell Therapeutics Q2 Adj. ...
08/12/2025 20:04:10

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimat...

lineage-cell-therapeutics-q2-eps-013-misses-003-estimate-sales-2765m-beat-1472m-estimate
Lineage Cell Therapeutics Q2 EPS $(0.13) M...
08/12/2025 20:02:41

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimat...

Core News & Articles
Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

a-peek-at-lineage-cell-therapeuticss-future-earnings
A Peek at Lineage Cell Therapeutics's Futu...
08/11/2025 20:02:34

d-boral-capital-maintains-buy-on-lineage-cell-therapeutics-maintains-2-price-target
D. Boral Capital Maintains Buy on Lineage ...
08/05/2025 11:50:25

D. Boral Capital analyst Jason Kolbert maintains Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $2 price tar...

lineage-cell-therapeutics-announced-the-first-chronic-spinal-cord-injury-patient-has-been-treated-in-the-companys-dosed-clinical-study-evaluating-a-new-parenchymal-spinal-delivery-system
Lineage Cell Therapeutics Announced The Fi...
08/04/2025 12:10:10

The DOSED study is designed to evaluate the safety and utility of a new parenchymal spinal delivery system, a novel delivery de...

d-boral-capital-maintains-buy-on-lineage-cell-therapeutics-maintains-2-price-target
D. Boral Capital Maintains Buy on Lineage ...
06/23/2025 13:26:16

D. Boral Capital analyst Jason Kolbert maintains Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $2 price tar...

two-biotech-stocks-poised-for-big-moves-on-monday
Two Biotech Stocks Poised For Big Moves On...
06/23/2025 11:39:03

hc-wainwright--co-reiterates-buy-on-lineage-cell-therapeutics-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Line...
06/23/2025 11:21:13

HC Wainwright & Co. analyst Joseph Pantginis reiterates Lineage Cell Therapeutics (AMEX:LCTX) with a Buy and maintains $...

lineages-opregen-shows-9-letter-bcva-gains-at-3-years-with-extensive-cell-coverage-in-phase-12a-trial-for-geographic-atrophy
Lineage's OpRegen Shows +9 Letter BCVA Gai...
06/23/2025 11:09:39

Mean vision gains of +9 letters among patients with extensive coverage of OpRegen cell therapy to the Geographic Atrophy (GA) l...

lineage-cell-therapeutics-q1-eps-002-beats-003-estimate-sales-150m-miss-187m-estimate
Lineage Cell Therapeutics Q1 EPS $(0.02) B...
05/13/2025 21:22:40

Lineage Cell Therapeutics (AMEX:LCTX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate ...

Core News & Articles
Earnings Scheduled For May 13, 2025
05/13/2025 08:32:43

examining-the-future-lineage-cell-therapeuticss-earnings-outlook
Examining the Future: Lineage Cell Therape...
05/12/2025 16:05:33

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION